Bristol-Myers Squibb Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2023
Total Assets: $95.16B
Liabilities Breakdown FY2023
Total Liabilities: $65.67B
Asset Breakdown
Total Assets: $95.16B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $11.46B | 12.0% |
| Accounts Receivable | $8.88B | 9.3% |
| Inventory | $2.66B | 2.8% |
| Property, Plant & Equipment | $6.65B | 7.0% |
| Goodwill | $21.17B | 22.2% |
| Intangible Assets | $27.07B | 28.4% |
| Other Assets | $17.26B | 18.1% |
Liabilities Breakdown
Total Liabilities: $65.67B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.26B | 5.0% |
| Long-Term Debt | $36.65B | 55.8% |
| Other Liabilities | $25.76B | 39.2% |